Keywords: avandia, implicated, again, hepatic, injury, sb, denies

Avandia implicated again in hepatic injury, SB denies link

Article | 19 January 2000

Under intense spotlight again, it has been reported that two patientsreceiving SmithKline Beecham's recently-launched antidiabetes drug Avandia (rosiglitazone) showed signs ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Avandia

rosiglitazone

Rezulin

Troglitazone

Go to drug listing